908 Devices Inc. (MASS) has a MoatMap StockRank of 77/100 based on Quality (44/100), Value (47/100), and Momentum (68/100) factor scores. The current signal is BUY. An early-stage mass spectrometry hardware provider that is currently unprofitable, failing the Terry Smith quality compounder filter despite interesting technology.
908 Devices Inc. develops and commercializes compact, handheld, and desktop mass spectrometry devices for rapid chemical and biochemical analysis across life science research and security markets. The company's competitive moat is based on its proprietary miniaturized mass spectrometry technology, offering unparalleled portability and ease of use compared to traditional laboratory instruments. 908 Devices is a disruptive innovator, democratizing access to advanced analytical capabilities for critical field and lab-based applications.
| Price | $7.93 |
| Market Cap | $338M |
| P/E (Forward) | -30.77 |
| Price/Book | 2.23 |
| Return on Equity | -24.1% |
| Return on Invested Capital | -16.5% |
| Debt/Equity | 3.33 |
| Gross Margin | 52.0% |
| Operating Margin | -48.6% |
| Revenue Growth | 13.6% |
| Free Cash Flow | $14M |
908 Devices Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).